One of the epigenetically upregulated genes in these oropharyngeal tumors, the Leukocyte immunoglobulin-like receptor B2 (LILRB2), has been shown to be overexpressed and is a tumor promoting gene in HCC as well (Li et al., 2018). The gene discussed is LILRB2; the disease is hepatocellular carcinoma.